Se ti disconnetti da Login UE, uscirai anche da tutti gli altri servizi che usano il tuo account Login UE. Utilizza il pulsante di disconnessione di CORDIS per rimanere connesso agli altri servizi.
Questa pagina sarà tradotta automaticamente dal servizio eTranslation della Commissione europea per facilitarne la comprensione. Leggi le condizioni d’uso.
Compensatory Evolution and Epistasis in Multidrug-resistant Mycobacterium tuberculosis
Final Report Summary - EVODRTB (Compensatory Evolution and Epistasis in Multidrug-resistant Mycobacterium tuberculosis)
Tuberculosis (TB) is the main cause of human death due to infection in general, and due to antimicrobial resistance (AMR) in particular. A long-standing dogma in the TB field has been that antibiotic-resistant TB bacteria were less virulent and less likely to transmit from person to person. Thus it was generally assumed that the problem of multidrug-resistant TB (MDR-TB) was mainly due to patient non-adherence to treatment. The findings from this project contradict this simplistic view by demonstrating that a substantial part of the MDR-TB problem can be attributed to direct transmission of MDR-TB bacteria from patient to patient. The reason for the enhanced spread of MDR-TB is that not all MDR-TB bacteria are the same; some carry additional mutations, so-called compensatory mutations, that mitigate the initial reduction of transmission fitness caused by the resistance-causing mutations. Importantly, this work showed that these compensatory mutations contribute to the transmission of MDR-TB independently of other known risk factors such as incarceration; prisons are known breeding-grounds for TB. This project also explored the molecular mechanisms of these phenomena and found that different strains of TB bacteria deal with drug resistance in different ways. As a consequence, the level of resistance to a given TB drug differs across drug-resistant strains, which has important implications of the diagnosis of MDR-TB in the clinic.